Advertisement
Research Article| Volume 90, ISSUE 3, P284-294, June 2018

Protective role of 6-formylindolo[3,2-b]carbazole (FICZ), an endogenous ligand for arylhydrocarbon receptor, in chronic mite-induced dermatitis

Published:February 21, 2018DOI:https://doi.org/10.1016/j.jdermsci.2018.02.014

      Highlights

      • FICZ upregulated the expression of filaggrin in keratinocytes via AHR.
      • In dermatitis-affected mouse skin, the expression of filaggrin was recovered by FICZ.
      • FICZ improved mite-induced chronic dermatitis and TEWL in NC/Nga mice.

      Abstract

      Background

      Chronic eczema such as atopic dermatitis imposes significant socio-econo-psychologic burdens on the affected individuals. In addition to conventional topical treatments, phototherapy is recommended for patients with extensive lesions. Although immunosuppression is believed to explain its primary effectiveness, the underlying mechanisms of phototherapy remain unsolved. Ultraviolet irradiation generates various tryptophan photoproducts including 6-formylindolo[3,2-b]-carbazole (FICZ). FICZ is known to be a potent endogenous agonist for aryl hydrocarbon receptor (AHR); however, the biological role of FICZ in chronic eczema is unknown.

      Objective

      To investigate the effect of FICZ on chronic eczema such as atopic dermatitis.

      Methods

      We stimulated HaCaT cells and normal human epidermal keratinocytes (NHEKs) with or without FICZ and then performed quantitative reverse transcriptase polymerase chain reaction, immunofluorescence, and siRNA treatment. We used the atopic dermatitis-like NC/Nga murine model and treated the mice for 2 weeks with either Vaseline® as a control, FICZ ointment, or betamethasone 17-valerate ointment. The dermatitis score, transepidermal water loss, histology, and expression of skin barrier genes and proteins were evaluated.

      Results

      FICZ significantly upregulated the gene expression of filaggrin in both HaCaT cells and NHEKs in an AHR-dependent manner, but did not affect the gene expression of other barrier-related proteins. In addition, FICZ improved the atopic dermatitis-like skin inflammation, clinical scores, and transepidermal water loss in NC/Nga mice compared with those of control mice. On histology, FICZ significantly reduced the epidermal and dermal thickness as well as the number of mast cells. Topical FICZ also significantly reduced the gene expression of Il22.

      Conclusion

      These findings highlight the beneficial role of FICZ-AHR and provide a new strategic basis for developing new drugs for chronic eczema.

      Abbreviations:

      FICZ (6-formylindolo[3,2-b]-carbazole), AHR (aryl hydrocarbon receptor), NHEKs (normal human epidermal keratinocytes), TEWL (transepidermal water loss), FLG (filaggrin), UV (ultraviolet)

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Dermatological Science
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Mimura J.
        • Fujii-Kuriyama Y.
        Functional role of AhR in the expression of toxic effects by TCDD.
        Biochim. Biophys. Acta. 1619; 2003: 263-268
        • Hao N.
        • Whitelaw M.L.
        The emerging roles of AhR in physiology and immunity.
        Biochem. Pharmacol. 2013; 86: 561-570
        • Furue M.
        • Takahara M.
        • Nakahara T.
        • Uchi H.
        Role of AhR/ARNT system in skin homeostasis.
        Arch. Dermatol. Res. 2014; 306: 769-779
        • Furue M.
        • Tsuji G.
        • Mitoma C.
        • Nakahara T.
        • Chiba T.
        • Morino-Koga S.
        • Uchi H.
        Gene regulation of filaggrin and other skin barrier proteins via aryl hydrocarbon receptor.
        J. Dermatol. Sci. 2015; 80: 83-88
        • Stockinger B.
        • Di Meglio P.
        • Gialitakis M.
        • Duarte J.H.
        The aryl hydrocarbon receptor: multitasking in the immune system.
        Annu. Rev. Immunol. 2014; 32: 403-432
        • Di Meglio P.
        • Duarte J.H.
        • Ahlfors H.
        • Owens N.D.
        • Li Y.
        • Villanova F.
        • Tosi I.
        • Hirota K.
        • Nestle F.O.
        • Mrowietz U.
        • Gilchrist M.J.
        • Stockinger B.
        Activation of the aryl hydrocarbon receptor dampens the severity of inflammatory skin conditions.
        Immunity. 2014; 40: 989-1001
        • Fritsche E.
        • Schäfer C.
        • Calles C.
        • Bernsmann T.
        • Bernshausen T.
        • Wurm M.
        • Hübenthal U.
        • Cline J.E.
        • Hajimiragha H.
        • Schroeder P.
        • Klotz L.O.
        • Rannug A.
        • Fürst P.
        • Hanenberg H.
        • Abel J.
        • Krutmann J.
        Lightening up the UV response by identification of the arylhydrocarbon receptor as a cytoplasmatic target for ultraviolet B radiation.
        Proc. Natl. Acad. Sci. U. S. A. 2007; 104: 8851-8856
        • Wincent E.
        • Amini N.
        • Luecke S.
        • Glatt H.
        • Bergman J.
        • Crescenzi C.
        • Rannug A.
        • Rannug U.
        The suggested physiologic aryl hydrocarbon receptor activator and cytochrome P4501 substrate 6-formylindolo[3,2-b]carbazole is present in humans.
        J. Biol. Chem. 2009; 284: 2690-2696
        • Hubbard T.D.
        • Murray I.A.
        • Perdew G.H.
        Indole and tryptophan metabolism: endogenous and dietary routes to ah receptor activation.
        Drug Metab. Dispos. 2015; 43: 1522-1535
        • Yamamoto M.
        • Haruna T.
        • Yasui K.
        • Takahashi H.
        • Iduhara M.
        • Takaki S.
        • Deguchi M.
        • Arimura A.
        A novel atopic dermatitis model induced by topical application with dermatophagoides farinae extract in NC/Nga mice.
        Allergol. Int. 2007; 56: 139-148
        • van den Bogaard E.H.
        • Bergboer J.G.
        • Vonk-Bergers M.
        • van Vlijmen-Willems I.M.
        • Hato S.V.
        • van der Valk P.G.
        • Schröder J.M.
        • Joosten I.
        • Zeeuwen P.L.
        • Schalkwijk J.
        Coal tar induces AHR-dependent skin barrier repair in atopic dermatitis.
        J. Clin. Invest. 2013; 123: 917-927
        • Takei K.
        • Mitoma C.
        • Hashimoto-Hachiya A.
        • Uchi H.
        • Takahara M.
        • Tsuji G.
        • Kido-Nakahara M.
        • Nakahara T.
        • Furue M.
        Antioxidant soybean tar Glyteer rescues T-helper-mediated downregulation of filaggrin expression via aryl hydrocarbon receptor.
        J. Dermatol. 2015; 42: 171-180
        • Palmer C.N.
        • Irvine A.D.
        • Terron-Kwiatkowski A.
        • Zhao Y.
        • Liao H.
        • Lee S.P.
        • Goudie D.R.
        • Sandilands A.
        • Campbell L.E.
        • Smith F.J.
        • O'Regan G.M.
        • Watson R.M.
        • Cecil J.E.
        • Bale S.J.
        • Compton J.G.
        • DiGiovanna J.J.
        • Fleckman P.
        • Lewis-Jones S.
        • Arseculeratne G.
        • Sergeant A.
        • Munro C.S.
        • El Houate B.
        • McElreavey K.
        • Halkjaer L.B.
        • Bisgaard H.
        • Mukhopadhyay S.
        • McLean W.H.
        Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis.
        Nat. Genet. 2006; 38: 441-446
        • Egawa G.
        • Kabashima K.
        Multifactorial skin barrier deficiency and atopic dermatitis: essential topics to prevent the atopic march.
        J. Allergy Clin. Immunol. 2016; 138: 350-358
        • Kawasaki H.
        • Nagao K.
        • Kubo A.
        • Hata T.
        • Shimizu A.
        • Mizuno H.
        • Yamada T.
        • Amagai M.
        Altered stratum corneum barrier and enhanced percutaneous immune responses in filaggrin-null mice.
        J. Allergy Clin. Immunol. 2012; 129: 1538-1546
        • Saunders S.P.
        • Moran T.
        • Floudas A.
        • Wurlod F.
        • Kaszlikowska A.
        • Salimi M.
        • Quinn E.M.
        • Oliphant C.J.
        • Núñez G.
        • McManus R.
        • Hams E.
        • Irvine A.D.
        • McKenzie A.N.
        • Ogg G.S.
        • Fallon P.G.
        Spontaneous atopic dermatitis is mediated by innate immunity: with the secondary lung inflammation of the atopic march requiring adaptive immunity.
        J. Allergy Clin. Immunol. 2016; 137: 482-491
        • Hou M.
        • Sun R.
        • Hupe M.
        • Kim P.L.
        • Park K.
        • Crumrine D.
        • Lin T.K.
        • Santiago J.L.
        • Mauro T.M.
        • Elias P.M.
        • Man M.Q.
        Topical apigenin improves epidermal permeability barrier homoeostasis in normal murine skin by divergent mechanisms.
        Exp. Dermatol. 2013; 22: 210-215
        • Tsuji T.
        • Okuno S.
        • Kuroda A.
        • Hamazaki J.
        • Chikami T.
        • Sakurai S.
        • Yoshida Y.
        • Banno R.
        • Fujita T.
        • Kohno T.
        Therapeutic approach to mite-induced intractable dermatitis using novel immunomodulator FTY720 ointment (fingolimod) in NC/Nga mice.
        Allergol. Int. 2016; 65: 172-179
        • Tsuji G.
        • Takahara M.
        • Uchi H.
        • Takeuchi S.
        • Mitoma C.
        • Moroi Y.
        • Furue M.
        An environmental contaminant benzo(a)pyrene, induces oxidative stress-mediated interleukin-8 production in human keratinocytes via the aryl hydrocarbon receptor signaling pathway.
        J. Dermatol. Sci. 2011; 62: 42-49
        • Chiba T.
        • Chihara J.
        • Furue M.
        Role of the arylhydrocarbon receptor (AhR) in the pathology of asthma and COPD.
        J. Allergy (Cairo). 2012; 2012: 372384
        • Kiss E.A.
        • Vonarbourg C.
        • Kopfmann S.
        • Hobeika E.
        • Finke D.
        • Esser C.
        • Diefenbach A.
        Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles.
        Science. 2011; 334: 1561-1565
        • Li Y.
        • Innocentin S.
        • Withers D.R.
        • Roberts N.A.
        • Gallagher A.R.
        • Grigorieva E.F.
        • Wilhelm C.
        • Veldhoen M.
        Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation.
        Cell. 2011; 147: 629-640
        • Haas K.
        • Weighardt H.
        • Deenen R.
        • Köhrer K.
        • Clausen B.
        • Zahner S.
        • Boukamp P.
        • Bloch W.
        • Krutmann J.
        • Esser C.
        Aryl hydrocarbon receptor in keratinocytes is essential for murine skin barrier integrity.
        J. Invest. Dermatol. 2016; 136: 2260-2269
        • Furue M.
        • Uchi H.
        • Mitoma C.
        • Hashimoto-Hachiya A.
        • Chiba T.
        • Ito T.
        • Nakahara T.
        • Tsuji G.
        Antioxidants for healthy skin: the emerging role of aryl hydrocarbon receptors and nuclear factor-erythroid 2-related factor-2.
        Nutrients. 2017; 9: 223
        • Zhou L.
        AHR function in lymphocytes: emerging concepts.
        Trends Immunol. 2016; 37: 17-31
        • Schiering C.
        • Wincent E.
        • Metidji A.
        • Iseppon A.
        • Li Y.
        • Potocnik A.J.
        • Omenetti S.
        • Henderson C.J.
        • Wolf C.R.
        • Nebert D.W.
        • Stockinger B.
        Feedback control of AHR signalling regulates intestinal immunity.
        Nature. 2017; 542: 242-245
        • Sutter C.H.
        • Bodreddigari S.
        • Campion C.
        • Wible R.S.
        • Sutter T.R.
        2,3,7,8-Tetrachlorodibenzo-p-dioxin increases the expression of genes in the human epidermal differentiation complex and accelerates epidermal barrier formation.
        Toxicol. Sci. 2011; 124: 128-137
        • Kennedy L.H.
        • Sutter C.H.
        • Leon Carrion S.
        • Tran Q.T.
        • Bodreddigari S.
        • Kensicki E.
        • Mohney R.P.
        • Sutter T.R.
        2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated production of reactive oxygen species is an essential step in the mechanism of action to accelerate human keratinocyte differentiation.
        Toxicol. Sci. 2013; 132: 235-249
        • Kypriotou M.
        • Huber M.
        • Hohl D.
        The human epidermal differentiation complex: cornified envelope precursors, S100 proteins and the ‘fused genes' family.
        Exp. Dermatol. 2012; 21: 643-649
        • Bergander L.
        • Wincent E.
        • Rannug A.
        • Foroozesh M.
        • Alworth W.
        • Rannug U.
        Metabolic fate of the Ah receptor ligand 6-formylindolo[3,2-b]carbazole.
        Chem. Biol. Interact. 2004; 149: 151-164
        • Monteleone I.
        • Rizzo A.
        • Sarra M.
        • Sica G.
        • Sileri P.
        • Biancone L.
        • MacDonald T.T.
        • Pallone F.
        • Monteleone G.
        Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract.
        Gastroenterology. 2011; 141: 237-248
        • Jeong K.T.
        • Hwang S.J.
        • Oh G.S.
        • Park J.H.
        FICZ, a tryptophan photoproduct, suppresses pulmonary eosinophilia and Th2-type cytokine production in a mouse model of ovalbumin-induced allergic asthma.
        Int. Immunopharmacol. 2012; 13: 377-385
        • Novac N.
        • Peng W.M.
        • Bieber T.
        • Akdis C.
        FcεRI stimulation promotes the differentiation of histamine receptor 1-expressing inflammatory macrophages.
        Allergy. 2013; 68: 454-461
        • Böhme M.
        • Söderhäll C.
        • Kull I.
        • Bergström A.
        • van Hage M.
        • Wahlgren C.F.
        Filaggrin mutations increase the risk for persistent dry skin and eczema independent of sensitization.
        J. Allergy Clin. Immunol. 2012; 129: 1153-1155
        • Czarnowicki T.
        • Esaki H.
        • Gonzalez J.
        • Malajian D.
        • Shemer A.
        • Noda S.
        • Talasila S.
        • Berry A.
        • Gray J.
        • Becker L.
        • Estrada Y.
        • Xu H.
        • Zheng X.
        • Suárez-Fariñas M.
        • Krueger J.G.
        • Paller A.S.
        • Guttman-Yassky E.
        Early pediatric atopic dermatitis shows only a cutaneous lymphocyte antigen (CLA)(+) TH2/TH1 cell imbalance, whereas adults acquire CLA(+) TH22/TC22 cell subsets.
        J. Allergy Clin. Immunol. 2015; 136: 941-951
        • Esaki H.
        • Brunner P.M.
        • Renert-Yuval Y.
        • Czarnowicki T.
        • Huynh T.
        • Tran G.
        • Lyon S.
        • Rodriguez G.
        • Immaneni S.
        • Johnson D.B.
        • Bauer B.
        • Fuentes-Duculan J.
        • Zheng X.
        • Peng X.
        • Estrada Y.D.
        • Xu H.
        • de Guzman Strong C.
        • Suárez-Fariñas M.
        • Krueger J.G.
        • Paller A.S.
        • Guttman-Yassky E.
        Early-onset pediatric atopic dermatitis is TH2 but also TH17 polarized in skin.
        J. Allergy Clin. Immunol. 2016; 138: 1639-1651
        • Guttman-Yassky E.
        • Ungar B.
        • Malik K.
        • Dickstein D.
        • Suprun M.
        • Estrada Y.D.
        • Xu H.
        • Peng X.
        • Oliva M.
        • Todd D.
        • Labuda T.
        • Suarez-Farinas M.
        • Bissonnette R.
        Molecular signatures order the potency of topically applied anti-inflammatory drugs in patients with atopic dermatitis.
        Clin. Immunol. 2018; https://doi.org/10.1016/j.jaci.2017.01.027
        • Lou H.
        • Lu J.
        • Choi E.B.
        • Oh M.H.
        • Jeong M.
        • Barmettler S.
        • Zhu Z.
        • Zheng T.
        Expression of IL-22 in the skin causes Th2-biased Immunity epidermal barrier dysfunction, and pruritus via stimulating epithelial Th2 cytokines and the GRP pathway.
        J. Immunol. 2017; 198: 2543-2555
        • Gutowska-Owsiak D.
        • Schaupp A.L.
        • Salimi M.
        • Taylor S.
        • Ogg G.S.
        Interleukin-22 downregulates filaggrin expression and affects expression of profilaggrin processing enzymes.
        Br. J. Dermatol. 2011; 165: 492-498
        • Nograles K.E.
        • Zaba L.C.
        • Shemer A.
        • Fuentes-Duculan J.
        • Cardinale I.
        • Kikuchi T.
        • Ramon M.
        • Bergman R.
        • Krueger J.G.
        • Guttman-Yassky E.
        IL-22-producing T22 T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells.
        J. Allergy Clin. Immunol. 2009; 123: 1244-1252
        • Qiu J.
        • Zhou L.
        Aryl hydrocarbon receptor promotes RORγt+ group 3 ILCs and controls intestinal immunity and inflammation.
        Semin. Immunopathol. 2013; 35: 657-670
        • Duarte J.H.
        • Di Meglio P.
        • Hirota K.
        • Ahlfors H.
        • Stockinger B.
        Differential influences of the aryl hydrocarbon receptor on Th17 mediated responses in vitro and in vivo.
        PLoS One. 2013; 8: e79819
        • Wollenberg A.
        • Oranje A.
        • Deleuran M.
        • Simon D.
        • Szalai Z.
        • Kunz B.
        • Svensson A.
        • Barbarot S.
        • von Kobyletzki L.
        • Taieb A.
        • de Bruin-Weller M.
        • Werfel T.
        • Trzeciak M.
        • Vestergard C.
        • Ring J.
        • Darsow U.
        • European Task Force on Atopic Dermatitis/EADV Eczema Task Force
        ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients.
        J. Eur. Acad. Dermatol. Venereol. 2016; 30: 729-747
        • Saeki H.
        • Nakahara T.
        • Tanaka A.
        • Kabashima K.
        • Sugaya M.
        • Murota H.
        • Ebihara T.
        • Kataoka Y.
        • Aihara M.
        • Etoh T.
        • Katoh N.
        • Committee for Clinical Practice Guidelines for the Management of Atopic Dermatitis of Japanese Dermatological Association
        Clinical practice guidelines for the management of atopic dermatitis 2016.
        J. Dermatol. 2016; 43: 1117-1145
        • Almutawa F.
        • Alnomair N.
        • Wang Y.
        • Hamzavi I.
        • Lim H.W.
        Systematic review of UV-based therapy for psoriasis.
        Am. J. Clin. Dermatol. 2013; 14: 87-109
        • Schwarz T.
        The dark and the sunny sides of UVR-induced immunosuppression: photoimmunology revisited.
        J. Invest. Dermatol. 2010; 130: 49-54
        • Navid F.
        • Bruhs A.
        • Schuller W.
        • Fritsche E.
        • Krutmann J.
        • Schwarz T.
        • Schwarz A.
        The Aryl hydrocarbon receptor is involved in UVR-induced immunosuppression.
        J. Invest. Dermatol. 2013; 133: 2763-2770
        • Hong S.P.
        • Kim M.J.
        • Jung M.Y.
        • Jeon H.
        • Goo J.
        • Ahn S.K.
        • Lee S.H.
        • Elias P.M.
        • Choi E.H.
        Biopositive effects of low-dose UVB on epidermis: coordinate upregulation of antimicrobial peptides and permeability barrier reinforcement.
        J. Invest. Dermatol. 2008; 128: 2880-2887